Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
1.
Eur J Public Health ; 32(6): 894-899, 2022 11 29.
Artigo em Inglês | MEDLINE | ID: mdl-36083204

RESUMO

BACKGROUND: The lack of systematic factors affecting physical inactivity (PIA) challenges policymakers to implement evidence-based solutions at a population level. The study utilizes the Eurobarometer to analyse PIA-modifiable variables. METHODS: Special Eurobarometer 412 physical activity (PA) data were analysed (n = 18 336), including 40 variables along with the International PA Questionnaire. PIA was used as the dependent variable. Variables considered were alternatives to car, places, reasons and barriers to engaging in PA, memberships to clubs and categorical responses about the agreement extent with the area, provision of activities and local governance statements. Logistic regression was used to identify variables contributing to PIA. Beta values (ß), standard errors, 95% confidence intervals, the exponentiation for odds ratio and Cox & Snell and Nagelkerke R2 were indicated. RESULTS: The resulting model correctly identified 10.7% inactives and 96.9% of actives (R2 of Nagelkerke: 0.153). Variables contributing to the detection of PIA were (P ≤ 0.01): having a disability or an illness, not having friends to do sport with, lacking motivation or interest in and being afraid of injury risk. Additionally, totally agreeing, tend to agree and tend to disagree regarding the extent of local providers offering enough opportunities to be more active also contributed to the model. CONCLUSIONS: The model reported a limited ability to detect modifiable factors affecting PIA, identifying a small percentage of inactive individuals correctly. New questions focused on understanding inactive behaviour are needed to support the European PA public health agenda.


Assuntos
Pessoas com Deficiência , Esportes , Humanos , Comportamento Sedentário , Exercício Físico , Motivação
2.
Rev Esp Quimioter ; 35(4): 307-332, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35277084

RESUMO

Ambient air quality, pollution and its implication on health is a topic of enormous importance that is normally dealt with by major specialists in their particular areas of interest. In general, it is not discussed from multidisciplinary approaches or with a language that can reach everyone. For this reason, the Health Sciences Foundation, from its prevention area, has formulated a series of questions to people with very varied competences in the area of ambient air quality in order to obtain a global panorama of the problem and its elements of measurement and control. The answers have been produced by specialists in each subject and have been subjected to a general discussion that has allowed conclusions to be reached on each point. The subject was divided into three main blocks: external ambient air, internal ambient air, mainly in the workplace, and hospital ambient air and the consequences of its poor control. Along with the definitions of each area and the indicators of good and bad quality, some necessary solutions have been pointed out. We have tried to know the current legislation on this problem and the competences of the different administrations on it. Despite its enormous importance, ambient air quality and health is not usually a topic of frequent presence in the general media and we have asked about the causes of this. Finally, the paper addresses a series of reflections from the perspective of ethics and very particularly in the light of the events that the present pandemic raises. This work aims to provide objective data and opinions that will enable non-specialists in the field to gain a better understanding of this worrying reality.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , Poluentes Atmosféricos/análise , Poluição do Ar/análise , Poluição do Ar/prevenção & controle , Causalidade , Exposição Ambiental/análise , Humanos , Pandemias
3.
Rev Clin Esp (Barc) ; 221(9): 497-508, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34752261

RESUMO

OBJECTIVES: The inappropriate and indiscriminate use of antibiotics is one of the main factors contributing to the onset of antimicrobial resistance. In 2007, the European Surveillance of Antimicrobial Consumption (ESAC) project established certain indicators to assess the quality of antibiotic use. We analysed the quality of antibiotic prescription in La Rioja (Spain) in 2017, using epidemiological (age, sex, seasonal nature) and financial variables (price of the antibiotic and income level). MATERIAL AND METHODS: Using data on monthly distributions of antibiotics (J01) through official prescriptions and prescriptions from medical insurance companies, we calculated the population rates for the number of prescriptions per 1000 inhabitants, as well as the values of 9 quality indicators (by antibiotic family, age group, sex and income), defined by ESAC, classifying the prescription quality as "very high", "high", "low" and "very low". RESULTS: The quality of antibiotic prescriptions in La Rioja in 2017 was "high" for antibiotics dispensed through official prescriptions (18.55 daily defined doses per 1000 inhabitants [DID]) and "low" for those dispensed through medical insurance companies (21.79 DID). When we included private prescriptions (26.02 DID), the quality was "very low", taking into account the margins indicated by ESAC. We detected high rates of prescription for broad-spectrum antibiotics for men older than 45 years, penicillins for women aged 25 to 39 years, quinolones for pensioners and cephalosporins for high-income patients. CONCLUSIONS: The quality of antibiotic prescription is determined not only by epidemiological variables, such as age and sex, but also by financial variables, such as patient income and antibiotic price.


Assuntos
Antibacterianos , Quinolonas , Antibacterianos/uso terapêutico , Cefalosporinas , Prescrições de Medicamentos , Feminino , Humanos , Masculino , Penicilinas , Padrões de Prática Médica
4.
Annu Int Conf IEEE Eng Med Biol Soc ; 2020: 3473-3476, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-33018751

RESUMO

Spatial and frequency characterization of sleep spindles have been extensively addressed using M/EEG or fMRI recordings. However, its intraindividual variability across time has not been addressed. Here we propose to assess the intraindividual variability of sleep spindles in a time-resolved way by means of a trial-to-trial-variability (TTV) measure. For that purpose, the EEG of 26 healthy subjects were recorded overnight. After an exhaustive preprocessing pipeline to remove artifacts, spindles were automatically detected using a complex demodulation-based method. Then, the Wavelet Scalogram was estimated to validate it. Spindle TTV of each participant was also computed for all the conventional EEG frequency bands. Root mean square (RMS) of each TTV signal was calculated as a measure of the total variability of each spindle. Results showed significant differences in the variability between frequencies. Specifically, RMS in the beta-1 frequency band showed higher values as compared to all the other frequency bands (p<0.001). TTV curves showed a dichotomic trend, with lower frequencies showing an increase in the variability before the spindle onset, and higher frequencies showing such increase after the onset. The dependence of the spindle variability with the frequency could be explained by the influence of the multiple cortical generators involved.Clinical Relevance- Sleep spindles are similarly affected in different cognitive-related disorders, which supports the relevance of assessing abnormal sleep patterns as a possible cause for such cognitive deficits.


Assuntos
Eletroencefalografia , Sono , Algoritmos , Artefatos , Voluntários Saudáveis , Humanos
5.
Rev Clin Esp ; 2020 Jun 09.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32532464

RESUMO

OBJECTIVES: The inappropriate and indiscriminate use of antibiotics is one of the main factors contributing to the onset of antimicrobial resistance. In 2007, the European Surveillance of Antimicrobial Consumption (ESAC) project established certain indicators to assess the quality of antibiotic use. We analysed the quality of antibiotic prescription in La Rioja (Spain) in 2017, using epidemiological (age, sex, seasonal nature) and financial variables (price of the antibiotic and income level). MATERIAL AND METHODS: Using data on monthly distributions of antibiotics (J01) through official prescriptions and prescriptions from medical insurance companies, we calculated the population rates for the number of prescriptions per 1000 inhabitants, as well as the values of 9 quality indicators (by antibiotic family, age group, sex and income), defined by ESAC, classifying the prescription quality as "very high", "high", "low" and "very low". RESULTS: The quality of antibiotic prescriptions in La Rioja in 2017 was "high" for antibiotics dispensed through official prescriptions (18.55 daily defined doses per 1000 inhabitants [DID]) and "low" for those dispensed through medical insurance companies (21.79 DID). When we included private prescriptions (26.02 DID), the quality was "very low", taking into account the margins indicated by ESAC. We detected high rates of prescription for broad-spectrum antibiotics for men older than 45 years, penicillins for women aged 25 to 39 years, quinolones for pensioners and cephalosporins for high-income patients. CONCLUSIONS: The quality of antibiotic prescription is determined not only by epidemiological variables, such as age and sex, but also by financial variables, such as patient income and antibiotic price.

6.
BMC Public Health ; 19(1): 1677, 2019 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-31830956

RESUMO

BACKGROUND: The World Health Organization (WHO) considers physical inactivity (PIA) as a critical noncommunicable factor for disease and mortality, affecting more women than men. In 2013, the WHO set a 10% reduction of the PIA prevalence, with the goal to be reached by 2025. Changes in the 2013-2017 period of physical inactivity prevalence in the 28 European Union (EU) countries were evaluated to track the progress in achieving WHO 2025 target. METHODS: In 2013 and 2017 EU Special Eurobarometers, the physical activity levels reported by the International Physical Activity Questionnaire of 53,607 adults were analyzed. Data were considered as a whole sample and country-by-country. A χ2 test was used to analyze the physical inactivity prevalence (%) between countries, analyzing women and men together and separately. Additionally, PIA prevalence was analyzed between years (2013-2017) for the overall EU sample and within-country using a Z-Score for two population proportions. RESULTS: The PIA prevalence increased between 2013 and 2017 for the overall EU sample (p <  0.001), and for women (p = 0.04) and men (p < 0.001) separately. Data showed a higher PIA prevalence in women versus men during both years (p <  0.001). When separately considering changes in PIA by gender, only Belgium's women and Luxembourg's men showed a reduction in PIA prevalence. Increases in PIA prevalence over time were observed in women from Austria, Croatia, Germany, Lithuania, Malta, Portugal, Romania, and Slovakia and in men from Bulgaria, Croatia, Czechia, Germany, Italy, Lithuania, Portugal, Romania, Slovakia, and Spain. CONCLUSIONS: PIA prevalence showed an overall increase across the EU and for both women and men between 2013 and 2017, with higher rates of PIA reported for women versus men during both years. PIA prevalence was reduced in only Belgium's women and Luxembourg's men. Our data indicate a limited gender-sensible approach while tacking PIA prevalence with no progress reaching global voluntary reductions of PIA for 2025.


Assuntos
Comportamento Sedentário , Fatores Sexuais , Adulto , União Europeia , Feminino , Objetivos , Humanos , Masculino , Inquéritos e Questionários , Organização Mundial da Saúde
7.
BMC Public Health ; 18(1): 1081, 2018 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-30165825

RESUMO

BACKGROUND: Physical inactivity (PIA) is a mortality risk factor defined as performing lower levels of physical activity than recommended by the World Health Organization (WHO). After 2002, the WHO released the WHA55.23 Resolution and the Global Strategy which produced several changes in policymaking, but with no subsequent analyses of the impact of these changes in European Union (EU) policymaking while examining PIA prevalence. METHODS: PIA of 31,946 adults as a whole sample and country-by-country were analyzed in the 2002 and 2005 EU Special Eurobarometers. PIA prevalence between countries was performed with the χ2 test and PIA between both years and between genders was analyzed with the Z-Score test for two population proportions. A retrospective analysis of national plans was performed to interpret the suitability of such policy documents, considering changes in PIA prevalence. RESULTS: Differences in PIA prevalence were observed between countries (p <  0.001) and years (p <  0.001) for the whole sample and men and women separately. Within-country samples showed no differences for Denmark, Finland, Ireland, Italy, Luxemburg, Portugal, and Spain (p > 0.05). When considering gender, there were no gender reductions in subsamples for Denmark, Finland, Ireland, Portugal, Spain, and United Kingdom, neither in Luxemburg for men, nor in France and Italy for women. When analyzing gender differences across the entire sample, PIA was higher in women than men for both years (p <  0.001). Greece and Luxemburg did not release national plans for promoting physical activity. CONCLUSIONS: While large differences in PIA prevalence between EU countries prevailed, the overall PIA descended between both years for the whole sample, men, and women. While this points out a general suitability of policymaking for reducing PIA, not all countries reported reductions in PIA for men, women, or both genders. Also, PIA levels were higher for women in both years, suggesting a less than optimal policy implementation, or lack of women-specific focus across the EU. This analysis helps to identify the strengths and weaknesses of PIA policymaking in the EU and provides researchers with targeted intervention areas for future development.


Assuntos
Exercício Físico , Fidelidade a Diretrizes/estatística & dados numéricos , Guias como Assunto , Política de Saúde , Formulação de Políticas , Adulto , União Europeia , Feminino , Humanos , Masculino , Pesquisa , Estudos Retrospectivos , Comportamento Sedentário , Fatores Sexuais , Organização Mundial da Saúde
8.
J Dairy Sci ; 101(8): 7095-7105, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29885898

RESUMO

Holstein cows (n = 30) were balanced by days in milk, milk production, and parity (91 ± 5.9 d in milk, 36.2 ± 2.5 kg/d, and 3.1 ± 1.4, respectively) and fed OmniGen-AF (OG; Phibro Animal Health, Teaneck, NJ), an immune stimulant, at 0 g/cow per d for control (CON) or 56 g/cow per d for OG for 52 d on a commercial dairy. At 52 d of the study cows were randomly selected (n = 12) from both groups (6 OG and 6 CON) and housed in environmentally controlled rooms at the Agricultural Research Complex for 21 d at the University of Arizona. Cows were subjected to 7 d of thermoneutral (TN) conditions, 10 d of heat stress (HS), and 4 d of recovery (REC) under TN conditions. Feed intake, milk production, and milk composition were measured daily. Rectal temperatures (RT) and respiration rates (RR) were recorded 3 times per day (600, 1400, and 1800 h). Blood samples were taken on d 7 (TN), 8 (HS), 10 (HS), 17 (HS), and 18 (TN) during the Agricultural Research Complex segment. Cows in HS had higher RR and RT and water intake and lower dry matter intake and milk yield than these measures in TN. There was a treatment × environment interaction with cows fed OG having lower RR and RT and higher dry matter intake during peak thermal loads than CON. However, milk yield did not differ between groups. Cows fed OG had lower milk fat percent than CON (3.7 vs 4.3%) during HS. The SCC content of milk did not differ between treatment groups but rose in both groups during the REC phase following HS. Plasma insulin and plasma glucose levels were not different between groups. However, plasma insulin in both groups was lower during acute HS, then rose across the HS period, and was highest during the REC phase. Plasma cortisol levels were highest in all cows on the first day of HS (d 8) but were lower in cows fed OG compared with CON. However, plasma ACTH concentrations were elevated in OG-fed animals at all times samples were collected. Plasma ACTH was also elevated in cows fed both OG and CON during HS. Feeding OG reduced plasma cortisol during acute but not chronic HS and increased basal plasma ACTH, suggesting that OG treatment may alter the hypothalamic pituitary adrenal axis.


Assuntos
Doenças dos Bovinos/fisiopatologia , Bovinos/fisiologia , Dieta , Transtornos de Estresse por Calor/veterinária , Leite/química , Ração Animal , Animais , Feminino , Transtornos de Estresse por Calor/fisiopatologia , Temperatura Alta , Sistema Hipotálamo-Hipofisário , Lactação , Sistema Hipófise-Suprarrenal , Gravidez
9.
J Dairy Sci ; 98(12): 8710-22, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26409968

RESUMO

Efficacy of 2 cooling systems (Korral Kool, KK, Korral Kool Inc., Mesa, AZ; FlipFan dairy system, FF, Schaefer Ventilation Equipment LLC, Sauk Rapids, MN) was estimated utilizing 400 multiparous Holstein dairy cows randomly assigned to 1 of 4 cooled California-style shade pens (2 shade pens per cooling system). Each shaded pen contained 100 cows (days in milk=58±39, milk production=56±18 kg/d, and lactation=3±1). Production data (milk yield and reproductive performance) were collected during 3mo (June-August, 2013) and physiological responses (core body temperature, respiration rates, surface temperatures, and resting time) were measured in June and July to estimate responses of cows to the 2 different cooling systems. Water and electricity consumption were recorded for each system. Cows in the KK system displayed slightly lower respiration rates in the month of June and lower surface temperatures in June and July. However, no differences were observed in the core body temperature of cows, resting time, feed intake, milk yield, services/cow, and conception rate between systems. The FF system used less water and electricity during this study. In conclusion, both cooling systems (KK and FF) were effective in mitigating the negative effects of heat stress on cows housed in arid environments, whereas the FF system consumed less water and electricity and did not require use of curtains on the shade structure.


Assuntos
Ar Condicionado/instrumentação , Bovinos/fisiologia , Indústria de Laticínios/instrumentação , Abrigo para Animais , Animais , Temperatura Corporal , Doenças dos Bovinos/prevenção & controle , Indústria de Laticínios/métodos , Meio Ambiente , Feminino , Transtornos de Estresse por Calor/prevenção & controle , Transtornos de Estresse por Calor/veterinária , Lactação/fisiologia , Leite/química , Reprodução/fisiologia , Taxa Respiratória , Arábia Saudita , Estações do Ano , Temperatura
10.
Neurologia ; 24(7): 465-84, 2009 Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-19921557

RESUMO

We present the Spanish adaptation made by the CEIPC of the European Guidelines on Cardiovascular Disease Prevention (CVD) in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to prevent premature mortality and morbidity due to CVD through the management of its related risk factors in clinical practice. The guide focuses on primary prevention and emphasizes the role of the nurses and primary care medical doctors in promoting a healthy life style, based on increasing physical activity, change dietary habits, and non smoking. The therapeutic goal is to achieve a Blood Pressure < 140/90 mmHg, but among patients with diabetes, chronic kidney disease, or definite CVD, the objective is <130/80 mmHg. Serum cholesterol should be < 200 mg/dl and cLDL<130 mg/dl, although among patients with CVD or diabetes, the objective is <100 mg/dl (80 mg/dl if feasible in very high-risk patients). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, and drugs must be administered whenever applicable, to reach body mass index (BMI) guided and waist circumference objectives. In diabetic type 2 patients, the objective is glycated haemoglobin <7%. Allowing people to know the guides and developing implementation programs, identifying barriers and seeking solutions for them, are priorities for the CEIPC in order to transfer the recommendations established into the daily clinical practice.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Medicina Clínica/normas , Fatores Etários , Biomarcadores , Pressão Sanguínea , Índice de Massa Corporal , Doenças Cardiovasculares/mortalidade , Doenças Cardiovasculares/fisiopatologia , Doenças Cardiovasculares/terapia , Colesterol/sangue , Ensaios Clínicos como Assunto , Diabetes Mellitus Tipo 2/prevenção & controle , Humanos , Estilo de Vida , Inibidores da Agregação Plaquetária/uso terapêutico , Padrões de Prática Médica , Fatores de Risco , Espanha
11.
Rev Clin Esp ; 209(6): 279-302, 2009 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-19635253

RESUMO

The present CEIPC Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to prevent premature mortality and morbidity due to CVD by means of dealing with its related risk factors in clinical practice. The guide focuses on primary prevention and emphasizes the role of the nurses and primary care doctors in promoting a healthy life style, based on increasing physical activity, changing dietary habits, and not smoking. The therapeutic goal is to achieve a Blood Pressure < 140/90 mmHg, but in patients with diabetes, chronic kidney disease, or definite CVD, the objective is < 130/80 mmHg. Serum cholesterol should be < 200 mg/dl and cLDL < 130 mg/dl, although in patients with CVD or diabetes, the objective is < 100 mg/dl (80 mg/dl if feasible in very high-risk patients). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, and drugs must be administered whenever applicable, with the objective guided by body mass index and waist circumference. In diabetic type 2 patients, the objective is glycated haemoglobin < 7%. Allowing people to know the guides and developing implementation programs, identifying barriers and seeking solutions for them, are priorities for the CEIPC in order to put the recommendations into practice.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Comportamento , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/psicologia , Doenças Cardiovasculares/terapia , Humanos , Hipertensão/complicações , Hipertensão/terapia , Fatores de Risco , Fatores Socioeconômicos , Espanha
12.
Eur Respir J ; 34(2): 340-5, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19251787

RESUMO

The endurance time during constant high work-rate exercise (t(LIM)) is used to assess exercise capacity in patients with chronic obstructive pulmonary disease and as an outcome measure for pulmonary rehabilitation. Our study was designed to establish the minimum clinically important difference for the t(LIM). t(LIM) was measured in 105 patients (86 males) before and after an 8-week outpatient pulmonary rehabilitation programme. Subjects were asked to identify, from a five-point Likert scale, the perceived change in their exercise performance immediately upon completion of the exercise tests. The scale ranged from "better" to "worse". The mean+/-sd age was 64+/-5 yrs, forced expiratory volume in 1 s (FEV(1)) 47+/-10% and FEV(1)/forced vital capacity 54.7+/-16.3%. Baseline t(LIM) at 75% of the peak work rate was 397+/-184 s, which increased by 62+/-63% after rehabilitation. In subjects who felt their exercise tolerance was "slightly better", the mean improvement was 34% in the relative improvement over the baseline value (95% CI 29-39)% or 101 (86-116) s compared with 121 (109-134)% in those who reported that their exercise tolerance was "better" and 8 (2-14)% in those who felt their exercise tolerance was "about the same". Minimum clinically important improvement for t(LIM) averaged approximately 33% of baseline. Patients were able to distinguish at least one further additional level of benefit at 120% of baseline.


Assuntos
Tolerância ao Exercício , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Doença Pulmonar Obstrutiva Crônica/reabilitação , Idoso , Exercício Físico , Teste de Esforço , Feminino , Volume Expiratório Forçado , Humanos , Masculino , Pessoa de Meia-Idade , Oximetria , Qualidade de Vida , Curva ROC , Reprodutibilidade dos Testes , Capacidade Vital
13.
An Med Interna ; 25(6): 291-3, 2008 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-19295978

RESUMO

Necrotizing fascitiis due to Streptococcus Pyogenes has a high mortality rate. Detection of the infection before it developes to the streptococcal toxic shock syndrome is quite challenging and its one of the main goals of its management because at this final stage the treatment is in most of the cases ineffective. In a secuence of events of the progression of the infection to shock, renal failure occurs before hipotension very often. We report the case of a 38-year-old patient affected by a fulminant necrotizing fascitiis by Streptococcus Pyogenes which presented at admission with lower leg cellulitis and acute renal failure.


Assuntos
Injúria Renal Aguda/etiologia , Celulite (Flegmão)/complicações , Fasciite Necrosante/complicações , Perna (Membro) , Choque Séptico , Infecções Estreptocócicas/complicações , Streptococcus pyogenes , Injúria Renal Aguda/diagnóstico , Adulto , Amputação Cirúrgica , Celulite (Flegmão)/diagnóstico , Fasciite Necrosante/diagnóstico , Evolução Fatal , Humanos , Perna (Membro)/cirurgia , Masculino , Choque Séptico/diagnóstico , Infecções Estreptocócicas/diagnóstico
16.
Burns ; 31(1): 67-71, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15639368

RESUMO

INTRODUCTION: Postoperative pain after surgery with patients suffering from burns tends to be moderate or severe, and its treatment requires a combination of high-strength analgesics (opioids) with others having different action mechanisms according to the concept of multimodal analgesia. AIMS: In this article we propose the use of continuous intravenous analgesia with morphine using elastomeric infusors at fixed dose for the treatment of this kind of pain. An evaluation is made of its analgesic efficacy, side effects and level of satisfaction. MATERIAL AND METHODS: A study was made of 17 burn patients operated on in our unit who received continuous intravenous analgesia during the postoperative period, with morphine at 1mg/h, using elastomeric infusors for a period of 24h. Its analgesic efficacy was analysed using the visual analogical scale (VAS) at different moments; side effects and the level of acceptance by the patient was also evaluated. RESULTS: The results confirm a good analgesic effect after 2h from starting perfusion (VAS < 3). The side effects reveal a similar or lesser incidence to the use of morphine in bolus or using the PCA system, and in no cases did they require treatment to be halted. The level of acceptance of the procedure by patients was good. CONCLUSION: This method reveals a high level of analgesic efficacy in the postoperative period with burn patients in this study. However, it is important to note the lower results obtained in the first hours of perfusion, and proposing a heavy initial dose of analgesics when starting perfusion. This is presented as an efficient analgesic method that is easy to apply, has a low cost, and the possibility of extending its indications to ambulatory treatment.


Assuntos
Analgésicos Opioides/administração & dosagem , Queimaduras/cirurgia , Elastômeros , Morfina/administração & dosagem , Dor Pós-Operatória/tratamento farmacológico , Adolescente , Adulto , Idoso , Analgesia Controlada pelo Paciente/métodos , Analgésicos Opioides/efeitos adversos , Pressão Sanguínea/fisiologia , Queimaduras/fisiopatologia , Feminino , Frequência Cardíaca/fisiologia , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Morfina/efeitos adversos , Medição da Dor/métodos , Dor Pós-Operatória/fisiopatologia , Satisfação do Paciente , Cuidados Pós-Operatórios/métodos
17.
Eur J Clin Nutr ; 57 Suppl 1: S18-21, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12947446

RESUMO

OBJECTIVE: To present the current burden of mortality attributable to some of the main cardiovascular risk factors in adults in Spain. METHODS: Mortality attributable to risk factors was calculated by combining their prevalence, the relative risks for death, and the number of deaths in Spain. Prevalence of hypertension (>/=140/90 mmHg), tobacco smoking, excess weight (body mass index >/=25 kg/m(2)), and self-reported diabetes were based on representative samples of the Spanish population in the 1990s. The relative risks came from valid international studies. RESULTS: About 14 000 total deaths (25% of all deaths) were attributable to hypertension in Spain's middle-aged population. A quarter of them were cardiovascular deaths. About 56 000 deaths were attributable to tobacco use in adults >/=35 y (16% of all deaths). Two-thirds of them were deaths for: lung cancer (26.5%), chronic obstructive pulmonary disease (20.9%), coronary heart disease (12.8%), and stroke (9.2%). About 28 000 deaths (8.5% of all deaths) were attributable to excess weight in adults. Two-thirds of them were cardiovascular deaths. About 2800 cardiovascular deaths were attributable to diabetes in adults >/=35 y (6% of all cardiovascular deaths). CONCLUSIONS: Mortality attributable to the risk factors studied is a major avoidable public health problem in Spain. The results presented are only illustrative but clearly show that there is considerable scope for prevention.


Assuntos
Doenças Cardiovasculares/mortalidade , Adulto , Idoso , Comorbidade , Diabetes Mellitus/mortalidade , União Europeia , Feminino , Humanos , Hipertensão/mortalidade , Masculino , Pessoa de Meia-Idade , Obesidade/mortalidade , Fatores de Risco , Distribuição por Sexo , Fumar/efeitos adversos , Fumar/mortalidade , Espanha
18.
Ann Chir ; 128(4): 246-50, 2003 May.
Artigo em Francês | MEDLINE | ID: mdl-12853021

RESUMO

Postoperative perineal hernia is a rare complication following abdominoperineal excision of the rectum. We report four cases illustrating its clinical presentation and modern management. Surgical technique for rectal excision and perineal closure, making of an epiplooplasty, postoperative infection may contribute to the occurrence of this complication. Mesh repair through an anterior open or laparoscopic abdominal approach is one of the surgical options if not contraindicated by age and/or general condition. Perineal or combined approaches can also be selected to solve this difficult problem.


Assuntos
Hérnia/etiologia , Períneo/cirurgia , Complicações Pós-Operatórias/etiologia , Reto/cirurgia , Idoso , Feminino , Hérnia/patologia , Humanos , Complicações Pós-Operatórias/patologia , Telas Cirúrgicas
19.
Aten Primaria ; 31(8): 493-9, 2003 May 15.
Artigo em Espanhol | MEDLINE | ID: mdl-12765587

RESUMO

OBJECTIVES: To evaluate the impact of type-2 diabetes mellitus (DM2) on the health-related quality of life (HRQL) of patients and to analyse the impact of social-demographic and clinical variables and of resource use. DESIGN: Cross-sectional study with retrospective and prospective information gathering (HRQL questionnaire). Setting. 29 primary care centres from the whole of Spain. PARTICIPANTS: 1041 patients diagnosed with DM2 after the age of 30, chosen at random from patients' records at participating centres. Main measurements. HRQL evaluated through the general questionnaire EQ-5D, which enabled HRQL of patients to be compared with that of the general Spanish population, obtained from a sample of 8963 people. RESULTS: Patients with DM2 had worse HRQL (mean EVA index of 0.71) than people in the general population of the same age and gender (mean EVA index of 0.81). Women, older patients and obese patients had worse HRQL. In clinical terms, patients with some DM2-related complication, deficient glycaemic control and in receipt of insulin treatment had worse HRQL than patients without complications, acceptably controlled patients or those receiving non-pharmacological or oral anti-diabetes treatment. CONCLUSIONS: DM2 is associated with worse HRQL for patients, and more so for patients with complications, poor control of glucaemia or under insulin treatment.


Assuntos
Diabetes Mellitus Tipo 2/psicologia , Atenção Primária à Saúde/estatística & dados numéricos , Qualidade de Vida , Idoso , Estudos Transversais , Diabetes Mellitus Tipo 2/epidemiologia , Feminino , Humanos , Masculino , Análise de Regressão , Estudos Retrospectivos , Espanha , Inquéritos e Questionários
20.
Value Health ; 6(2): 126-36, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12641863

RESUMO

OBJECTIVE: The objective of this study was to determine the cost-effectiveness of thromboprophylaxis with enoxaparin versus no thromboprophylaxis in patients with acute medical illness in Spain from the society perspective. METHODS: Markov process analysis techniques were used to model the health economic outcomes. Clinical data were derived mainly from the MEDENOX trial, while health-care utilization was derived from Delphi panels. RESULTS: An analysis over the MEDENOX trial period shows that the cost per event avoided is currency 432, while the cost per life saved is currency 1527. The cost per event includes all medical resource utilization costs associated with the event. The lifetime model, which assumes no higher risk for recurrence of venous thromboembolism (VTE) and mortality in asymptomatic patients, shows that the use of enoxaparin leads a cost per event avoided of currency 270 and cost per life-year gained of currency 71. If the lifetime model assumes a higher risk for recurrence of VTE in asymptomatic patients, enoxaparin is dominant over no thromboprophylaxis. CONCLUSION: The results showed that the favorable clinical benefit of enoxaparin as thromboprophylaxis in patients with acute medical illness, which was observed in the MEDENOX trial, results in a positive health economic benefit in both the short term and the long term in the health-care setting of Spain.


Assuntos
Anticoagulantes/economia , Anticoagulantes/uso terapêutico , Enoxaparina/economia , Enoxaparina/uso terapêutico , Tromboembolia/prevenção & controle , Doença Aguda , Ensaios Clínicos como Assunto , Análise Custo-Benefício , Árvores de Decisões , Humanos , Cadeias de Markov , Recidiva , Fatores de Risco , Espanha/epidemiologia , Tromboembolia/complicações , Tromboembolia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA